Zusammenfassung
Es besteht heute kein Zweifel mehr, dass die chirurgische Therapie mit kurativer Zielsetzung einen festen Platz in der Behandlung von Fernmetastasen und lokalen Rezidiven kolorektaler Karzinome hat. Dies gilt auch für das lokal rezidivierte Rektumkarzinom. Die operative Therapie ist aufwendig, doch besteht eine Aussicht auf Heilung, wenn das Rezidiv komplett entfernt werden kann. Die Induktionstherapie mit Radiochemotherapie hat die Resektabilität des Rezidives deutlich verbessert, die Morbidität der Eingriffe bleibt jedoch hoch. Dagegen ist die Mortalität mit ca. 3% akzeptabel. Nach kompletter (R0-)Resektion kann ein 5-Jahres-Überleben von etwa 25% erwartet werden.
Abstract
There is no doubt that surgical treatment with curative intent is warranted in patients with recurrent colorectal cancer. This is also true for locally recurrent rectal cancer. Operative procedures are demanding but may be curative if complete excision can be achieved. Preoperative radiochemotherapy has helped to improve resectability, but operative morbidity is still high. Procedure-related mortality on the other hand is low, at around 3%, and 25% 5-year survival can be expected after complete excision.
Literatur
Arnaud JP, Nordlinger B, Bosset JF G et al. (1997) Radical surgery and postoperative radiotheraopy as a acombined treatment in rectal cancer. Final results of a phase III study of the European Organization for Research and Treatment of Cancer. Br J Surg 84:352
Balzer JO, Luboldt W, Vogl TJ (2003) Wertigkeit der CT und MRT bei der Rezidivdiagnostik des kolorektalen Karzinoms. Radiologe 43:122
Brophy PF, Hoffmann JP, Eisenberg BL (1994) The role of palliative pelvic exenteration. Am J Surg 167:386
Compton CC (2002) Pathologic prognostic factors in the recurrence of rectal cancer. Clin Colorectal Cancer 2: 149
Dorrance HR, Docherty GM, O’Dwyer PJ (2000) Related Articles, Links Effect of surgeon specialty interest on patient outcome after potentially curative colorectal cancer surgery. Dis Colon Rectum 43:492
Esnola NF, Cantor SB, Johnson M et al. (2002) Pain and Quality of Life after treatment in patients with locally recurrent rectal cancer. J Clin Oncol 20:4361
Glimelius B (2003) Recurrent rectal cancer: the pre-irradiated primary tumor. Can more radiotherapy be given? Colorectal Disease 5:501
Goldberg PA, Nicholls RJ, Porter NH, Loce S, Grimsey JE (1994) Long term results of a randomised trial of short course low dose adjuvant preoperative radiotherapy for rectal cancer: reduction in local treatment failure. Eur J Cance r 30A: 1602
Hahnloser D, Nelson H, Gunderson LL et al. (2003) Curative potential of multimodality therapy for locally recurrent rectal cancer. Ann Surg 237:502
Heald RJ, Husband EM, Ryall RD (1982) The mesorectum in rectal cancer surgery--the clue to pelvic recurrence? Br J Surg 69:613
Heald RJ, Smedh RK, Kald A, Sexton R, Moran BJ (1997) Abdominoperineal resection—an endangered operation ? Dis Colon Rectum 40:747–751
Hermanek P (1999) Impact of surgeon’s technique on outcome after treatment of rectal carcinoma. Dis Colon Rectum 1999; 42:559
Höcht S, Mann B, Germer CT et al. (2003) Pelvic sidewall involvement in recurrent rectal cancer. Int J Colorectal Dis DOI: 10.007/s00384-003-0544-6
Holm T, Johansson H, Cedermark B, Ekelund G, Rutqvist LE (1997) Influence of hospital- and surgeon-related factors on outcome after treatment of rectal cancer with or without preoperative radiotherapy. Br J Surg 84:657–63
Hruby G, Barton M, Miles S, Carroll S, Nasser E, Stevens G (2003) Sites of local recurrence after surgery, with or without chemotherapy, for rectal cancer: implications for radiotherapy field design. Int J Rad Oncol Biol Phys 55:138
Kapitejin E, Marjinen CAM, Nagtetaal ID et al. (2001) Preoperative Radiotherapy combined with total mesorectal excision for resectable rectal cancer. NEJM 345:638–646
Kuntz Ch, Lehnert T, Herfarth C (1995) Lokale Spätrezidive nach Rektumkarzinom. Akt Chir 30:261
Lehnert T, Golling M (2001) Hintere Beckenexenteration beim locoregionären Rezidiv des Rectumcarcinoms—Indikarion, Technik und Ergebnisse. Chirurg 72: 1393
Lehnert T, Herfarth C (1998) Multimodal therapy of rectal carcinoma. Chirurg 69:384
Lehnert T, Treiber M, Tiefenbacher U, Herfarth C, Wannenmacher M (2001) Intraoperative Radiotherapy for gastrointestinal tumors. Sem Surg Oncol 20:40
Luna-Perez P, Reyna Huelga A et al. (1999) The surgeon as prognostic factor for local recurrence and survival in the anal sphincter preservation for mid-rectal cancer. Rev Invest Clin 51:205
Mannaerts G, Rutten H, Martjin H et al. (2001) Comparison of intraoperative radiation therapy comtaining multimodality treatment with historical treatment modalities for locally recurrent rectal cancer. Dis Colon rectum 44:1749
Miner TJ, Jaques DP, Paty PB, Guillem JG, Wong WD (2003) Symptom control in patients with locally recurrent rectal cancer. Ann Surg Oncol 10:72
Moore HG, Akhurst T, Larson S, Minsky B, Mazumdar M, Guillem JG (2003) A case-controlled study of 18-fluorodeoxyglucose positron emission tomography in the detection of pelvic recurrence in previously irradiated rectal cancer patients. J Am Coll Surg 197:22
MRC Rectal Cancer Working Group (1996) Randomised trial of surgery alone versus radiotherapy followed by surgery for potentially operable locally advanced rectal cancer. Lancet 348:1610
Pietra N, Sarli L, Costi R, Ouchemi C, Grattarola M, Peracchia A (1998) Role of follow-up in management of local recurrences of colorectal cancer. Dis Colon Rectum 41:1127
Porter GA, Soskolne CL, Yakimets WW, Newman SC (1998) Surgeon-related factors and outcome in rectal cancer. Ann Surg 227:157
Sause WT, Pajak TF, Noyes RD et al. (1994) Evaluation of preoperative radiotherapy in operable colorectal cancer. Ann Surg 220:668
Schumpelick V, Braun J (1995) Das Sakralrezidiv des Rectumcarcinoms. Chirurg 66:931
Staib L, Schirrmeister H, Reske SN, Beger HG (2000) Is 18F-fluoro-deoxyglucose positron emmission tomography in recurrent cancer a contribution to surgical decision making ? Am J Surg 180:1
Stockholm Colorectal Cancer Study Group (1996) Randomized Study on preoperative radiotherapy in rectal carcinoma. Ann Surg Oncol 3:423
Swedish Rectal Cancer Trial (1997) Improved Survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 336:980
Tveit KM, Guldvog I, Hagen S et al. (1997) Randomized controlled trial of postoperative radiotherapy and short term time-scheduled 5-fluoro-uracil against surgery alone in the treatment of Dukes‘ B and C Rectal cancer. Norwegian Adjuvant Rectal Cancer Project Group.Br J Surg 84:1130
Wiggers T, Mannaerts GHH, Marinelli AWKS, Martjin H, Rutten H (2003) Surgery for locally recurrent rectal cancer. Colorectal Dis 5:504
Wiig JN, Tveit KM, Poulsen JP et al. (2002) Preoperative irradiation and surgery for recurrent rectal cancer. Will intraoperative radiotherapy be of additional benefit ? Radiother Oncol 62:207
Yamamoto S, Yamanaka N, Maeda T et al. (2001) Ileal neobladder for urinary bladder replacement following total pelvic exenteration for rectal carcinoma. Dig Surg 18:67
Interessenkonflikt:
Keine Angaben
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lehnert, T., Golling, M. & Buchholz, J. Lokoregionäres Rezidiv des Rektumkarzinoms. Chirurg 75, 38–44 (2004). https://doi.org/10.1007/s00104-003-0795-3
Issue Date:
DOI: https://doi.org/10.1007/s00104-003-0795-3